Who We Help
A Better Way to Treat Patients Suffering from Depression
Three out of five patients suffering from major depressive disorder are underserved by their antidepressant medications or have not found a medication that offers lasting remission.10,14,26
STAR*D Study: The Limitations of Antidepressants
The largest prospective clinical trial of MDD ever conducted, STAR*D showed that treatment resistance causes a patient’s chance for remission to decrease with each subsequent medication attempt.9,18,21,23
The STAR*D study additionally showed that the discontinuation of antidepressants due to side effects increases with each treatment attempt.9,18,21,23
Patients are Ready for a New Treatment Solution
Based on a recent market research study of 500 patients diagnosed with depression, NeuroStar found that 67% of patients with MDD are not happy with their current treatment and quality of life, and are actively searching for new treatment solutions.
NeuroStar® Advanced Therapy for Mental Health is here to help you help these patients.
A non-invasive therapeutic alternative for patients suffering from MDD, NeuroStar addresses many of the key limitations of existing treatment options and has shown an 83% response rate and a 62% remission rate in real-world** outcomes.5,22
NeuroStar provides you with clinically demonstrated response and remission, durable results, a demonstrated safety profile with limited side effects, and high patient adherence.8,11,12 NeuroStar also allows you to offer precise, reproducible office-based therapy that is convenient for both you and your patients.
Start Transforming Lives
See how NeuroStar can help you transform the lives of patients who have not yet found lasting remission from their depression.Contact A Rep